X0306 4 2014-06-20 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001384243 Quart Barry D 33 HAYDEN AVE LEXINGTON MA 02421 true false false false Common Stock 2014-06-20 4 M false 1375 25 A 1375 D Common Stock 2014-06-20 4 S false 1375 100 D 0 D Stock Option (Right to Buy) 25 2014-06-20 4 M false 1375 0 D 2017-08-14 Common Stock 1375 0 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014. The reporting person previously transferred an option to purchase 1,375 Shares of the original 2,750 granted under this stock option, which transfer was not reported as permitted under Rule 16a-12 of the Securities Exchange Act. The stock option granted the reporting person an option to purchase 2,750 Shares. All of these options vested and first became exercisable on August 14, 2008. These stock options were granted pursuant to the Trimeris, Inc. Amended and Restated Stock Incentive Plan. /s/ Thomas W. Beetham, Attorney-in-Fact 2014-06-24